A 1 HIS 3 0.048 -0.303 <=B
A 2 ARG 1 -0.724 -0.756 <=B
A 3 GLY 5 -5.454 -5.402
A 4 GLU 0 -9.087 -8.042
A 5 PHE 13 -11.706 -11.855
A 6 SER 19 -14.753 -15.241
A 7 VAL 17 -15.780 -15.921
A 8 CYS 24 -18.331 -18.983
A 9 ASP 8 -17.604 -16.499
A 10 SER 22 -19.016 -19.359
A 11 VAL 7 -17.182 -16.011
A 12 SER 7 -16.901 -15.762
A 13 VAL 11 -14.426 -14.032
A 14 TRP 5 -12.743 -11.852
A 15 VAL 21 -13.253 -14.144
A 16 GLY 4 -9.766 -9.103
A 17 ASP 1 -8.979 -8.061
A 18 LYS 31 -10.074 -12.480
A 19 THR 1 -8.246 -7.413
A 20 THR 4 -8.962 -8.392
A 21 ALA 34 -10.952 -13.602
A 22 THR 10 -9.539 -9.592
A 23 ASP 20 -7.728 -9.139
A 24 ILE 10 -6.058 -6.512
A 25 LYS 9 -3.342 -3.993
A 26 GLY 0 -4.442 -3.931
A 27 LYS 14 -3.655 -4.845
A 28 GLU 3 -4.304 -4.154
A 29 VAL 27 -6.226 -8.615
A 30 MET 10 -6.104 -6.552
A 31 VAL 24 -7.822 -9.682
A 32 LEU 20 -7.352 -8.806
A 33 GLY 4 -6.628 -6.326
A 34 GLU 5 -6.733 -6.534
A 35 VAL 17 -6.790 -7.965
A 36 ASN 3 -4.719 -4.521
A 37 ILE 10 -4.302 -4.958
A 38 ASN 0 -1.332 -1.178 <=B
A 39 ASN 0 -1.162 -1.029 <=B
A 40 SER 5 -2.441 -2.735 <=B
A 41 VAL 4 -4.816 -4.722
A 42 PHE 11 -6.356 -6.890
A 43 LYS 8 -7.032 -7.144
A 44 GLN 26 -8.103 -10.161
A 45 TYR 6 -10.566 -10.041
A 46 PHE 31 -14.141 -16.079
A 47 PHE 0 -15.505 -13.722
A 48 GLU 22 -17.927 -18.395
A 49 THR 14 -19.597 -18.953
A 50 LYS 11 -19.415 -18.447
A 51 CYS 20 -20.135 -20.119
A 52 ARG 10 -17.076 -16.263
A 53 ASP 6 -14.653 -13.658
A 54 PRO 8 -14.463 -13.719
A 55 ASN 26 -13.220 -14.689
A 56 VAL 0 -10.630 -9.408
A 57 ASP 7 -10.223 -9.852
A 58 GLY 14 -12.487 -12.661
A 59 CYS 22 -14.442 -15.311
A 60 ARG 13 -12.243 -12.330
A 61 GLY 11 -10.315 -10.394
A 62 ILE 23 -10.548 -11.980
A 63 ASP 5 -6.850 -6.638
A 64 SER 10 -6.534 -6.933
A 65 LYS 0 -2.951 -2.611 <=B
A 66 HIS 3 -4.191 -4.054
A 67 TRP 14 -7.751 -8.469
A 68 ASN 4 -8.869 -8.309
A 69 SER 21 -12.680 -13.637
A 70 TYR 7 -14.528 -13.662
A 71 CYS 23 -19.052 -19.506
A 72 THR 9 -18.907 -17.767
A 73 THR 19 -19.931 -19.824
A 74 THR 10 -19.326 -18.253
A 75 HIS 12 -17.512 -16.878
A 76 THR 11 -16.850 -16.177
A 77 PHE 13 -14.112 -13.984
A 78 VAL 20 -11.691 -12.647
A 79 LYS 3 -9.001 -8.311
A 80 ALA 35 -8.792 -11.806
A 81 LEU 14 -7.883 -8.586
A 82 THR 27 -7.218 -9.493
A 83 MET 12 -5.338 -6.104
A 84 ASP 16 -4.349 -5.689
A 85 GLY 2 -2.934 -2.826 <=B
A 86 LYS 0 -2.093 -1.852 <=B
A 87 GLN 8 -3.422 -3.949
A 88 ALA 9 -5.301 -5.727
A 89 ALA 14 -5.721 -6.673
A 90 TRP 6 -6.338 -6.299
A 91 ARG 24 -6.751 -8.735
A 92 PHE 7 -8.573 -8.392
A 93 ILE 28 -11.119 -13.060
A 94 ARG 14 -13.765 -13.792
A 95 ILE 26 -16.096 -17.235
A 96 ASP 20 -19.144 -19.242
A 97 THR 11 -19.369 -18.406
A 98 ALA 8 -20.685 -19.226
A 99 CYS 22 -21.692 -21.727
A 100 VAL 9 -20.720 -19.372
A 101 CYS 20 -17.847 -18.094
A 102 VAL 10 -15.202 -14.604
A 103 LEU 11 -12.347 -12.192
A 104 SER 7 -8.983 -8.755
A 105 ARG 0 -6.146 -5.439
A 106 LYS 10 -2.843 -3.666 <=B

Identified 9 B-Cell epitope residues out of 106 total residues